Familial aggregation of bladder cancer;Familijarna agregacija raka mokraćne bešike

Vojnosanitetski Pregled

Volumn 68, Issue 5, 2011, Pages 447-451

  Ilić, Milena ^a   Stojadinović, Miroslav ^b   Milosavljević, Zoran ^c  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b Department of Histology ^*  (Serbia)

^c CLINICAL CENTER KRAGUJEVAC   (Serbia)

Author keywords

Carcinoma; Family; Papillary; Transitional cell; Urinary bladder neoplasms

Indexed keywords

AMMONIA; DRINKING WATER; PERMANGANATE POTASSIUM; WELL WATER;

ADULT; AGE; AGED; AGRICULTURAL WORKER; ARTICLE; BIRTHPLACE; BLADDER CANCER; CANCER GRADING; CANCER INFILTRATION; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HEMATURIA; HUMAN; MALE; MEDICAL HISTORY; NUTRITION; SUBMUCOSA; TRANSITIONAL CELL CARCINOMA; URINARY FREQUENCY; WATER ANALYSIS; WATER SUPPLY;

AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; ENVIRONMENTAL EXPOSURE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; RURAL POPULATION; URINARY BLADDER NEOPLASMS;

EID: 79957625310     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1105447I     Document Type: Article

References (23)

1. Piper JM, Matanoski GM, Tonascia J. Bladder cancer in young women. Am J Epidemiol 1986; 123(6): 1033-1042.
2. Kunze E, Chang-Claude J, Frentzel-Beyrne R. Life style and occupational risk factors for bladder cancer in Germany. A casecontrol study. Cancer 2006; 69(7): 1776-90.
3. Kogevinas M, 't Mannetje A, Cordier S, Ranft U, González CA, Vineis P, et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 2003; 14(10): 907-14.
4. Ji J, Granström C, Hemminki K. Occupation and bladder cancer: a cohort study in Sweden. Br J Cancer 2005; 92(7): 1276-8.
5. Augustine A, Hebert JR, Kabat GC, Wynder EL. Bladder cancer in relation to cigarette smoking. Cancer Res 1988; 48(15): 4405-8.
6. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000; 86(2): 289-94.
7. Samanic C, Kogevinas M, Dosemeci M, Malats N, Real FX, Garcia-Closas M, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 2006; 15(7): 1348-54.
8. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 2007; 67(15): 7540-5.
9. Vineis P, Marinelli D, Autrup H, Brockmoller J, Cascorbi I, Daly AK, et al. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies. Cancer Epidemiol Biomarkers Prev 2001; 10(12): 1249-52.
10. Chiou HY, Chiou ST, Hsu YH, Chou YL, Tseng CH, Wei ML, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis- endemic area in northeastern Taiwan. Am J Epidemiol 2001; 153(5): 411-418.
11. Kurttio P, Pukkala E, Kahelin H, Auvinen A, Pekkanen J. Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 1999; 107(9): 705-10.
12. Nikolić J, Djokić M, Crnomarković D, Marinković J. Upper urothelial tumors and Balkan endemic nephropathy-dose responsible diseases. Facta Univ Ser Med Biol 2002; 9(1): 114-8.
13. Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Bladder cancer risk as modified by family history and smoking. Cancer 2006; 107(4): 705-11.
14. Kiemeney LA, Schoenberg M. Familial transitional cell carcinoma. J Urol 1996; 156(3): 867-72.
15. Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell carcinoma. Int J Cancer 2002; 98(2): 274-8.
16. Randi G, Pelucchi C, Negri E, Talamini R, Galeone C, Franceschi S, et al. Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers. Int J Cancer 2007; 121(12): 2748-52.
17. Murta-Nascimento C, Silverman DT, Kogevinas M, García-Closas M, Rothman N, Tardón A, et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 2007; 16(8): 1595-600.
18. Plna K, Hemminki K. Familial bladder cancer in the National Swedish Family Cancer Database. J Urol 2001; 166(6): 2129-33.
19. García-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer.Study and meta-analyses. Lancet 2005; 366(9486): 649-59.
20. Kantor AF, Hartge P, Hoover RN, Fraumeni JF Jr. Familial and environmental interactions in bladder cancer risk. Int J Cancer 1985; 35(6): 703-6.
21. Bermejo JL, Sundquist J, Hemminki K. Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden. Int J Cancer 2009; 124(9): 2166-71.
22. Petrovic B. Epidemiological study of bladder cancer [dissertation]. Niš: School of Medicine; 1996. (Serbian)
23. Radosavljevic V. Epidemiological research of risk factors for the occurrence of urinary bladder cancer [dissertation]. Belgrade: School of Medicine; 1999. (Serbian)